Interview/Debate – Falar Global

At the Falar Global show, discussing with Reginaldo Rodrigues de Almeida new technologies in medicine, like genomics and bioinformatics, and the future (and present) of medicine

At the Falar Global show, discussing with Reginaldo Rodrigues de Almeida new technologies in medicine, like genomics and bioinformatics, and the future (and present) of medicine
I gave a talk at the Escola Superior de Tecnologias da Saúde, a school that trains for many of the health professions, such as physiotherapists, opticians, nutritionists, pathology technicians, etc. I Discussed:
Published on LinkedIn on Nov 17th The diagnostics sector faces a paradox: we’re living through a precision medicine revolution, yet the tools that make precision medicine possible remain chronically underfunded. In 2023-2024, diagnostics captured just $2.2 billion in global venture funding, while AI companies raised over $100 billion globally in 2024. Even within healthcare, nearly…
I gave a talk about genomics and the development of precision medicine approaches in Asma at the ASIA meeting 2018 (Associação de Serviços e Unidades de Alergologia). I discussed the challenges of establishing a genomics-based precision medicine approach to asthma, from the determination of a priori risks from one’s genetic backgrounders, to the study of…
I have had this conversation over and over again, so I decided to lay out some arguments here. I am convinced that we are on the brink of a major change in the way medicine is practiced for two reasons. The first, which I will leave for another occasion is the empowerment of the individual…
BIÓPSIA LÍQUIDA, O “SANTO GRAAL” DA MEDICINA QUE É BARATO E EFICAZ NA DETEÇÃO DO CANCRO A biópsia líquida é um exame médico padronizado que tem ganho atenção científica mas também mediática pelas suas potencialidades na deteção precoce de várias doenças, nomeadamente as patologias oncológicas. Estivemos à conversa com o investigador José Leal, diretor executivo…
Interview in the news channel SIC Notícias for “Programa da manhã”, on 11.11.2011, about Bioinformatics in Cancer Research, in the context of the Harvard Medical School Portugal Program.